Tandem Diabetes Care (TNDM) Invested Capital (2013 - 2025)

Tandem Diabetes Care (TNDM) has reported Invested Capital for 9 consecutive years, with $155.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital fell 48.92% year-over-year to $155.2 million; the trailing twelve-month figure through Dec 2025 stood at $155.2 million (down 48.92% YoY), and the FY2025 full-year result was $155.2 million, down 48.92% from the prior year.
• Invested Capital improved to $155.2 million in Q4 2025 per TNDM's latest filing, from $133.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $313.6 million in Q4 2023 and bottomed at $133.0 million in Q3 2025.
• Historically, Invested Capital has averaged $223.4 million across 3 years, with a median of $235.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Invested Capital retreated 3.15% in 2024, then sank 52.22% in 2025.
• Over 3 years, Invested Capital stood at $313.6 million in 2023, then slipped by 3.15% to $303.8 million in 2024, then tumbled by 48.92% to $155.2 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $155.2 million, $133.0 million, and $133.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.